The 32 most recent market catalysts affecting $WELL, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 14, 2026
Corporate Catalyst
Bullish
Impact 65
Welltower Acquires Nine Nursing Homes in South Florida for $386 Million
Welltower Inc. has announced the acquisition of nine nursing homes in South Florida for $386 million, a move that significantly expands its healthcare real estate portfolio. This t…
Nov 14, 2026
Corporate Catalyst
Neutral
Impact 75
Welltower to Divest $1.3 Billion in Integra-Related Nursing Home Assets
Welltower Inc. is selling $1.3 billion worth of nursing home assets associated with Integra. This divestment is a strategic decision to optimize its healthcare infrastructure portf…
Nov 13, 2026
Corporate Catalyst
Bullish
Impact 55
Baird Adjusts Price Target on Welltower to $248 From $233
Baird, an investment firm, has raised its price target for Welltower (WELL) from $233 to $248. This upward revision indicates a more favorable view of the company's financial prosp…
Nov 12, 2026
Corporate Catalyst
Neutral
Impact 75
WELL Health Technologies Analyst Update and Q3 Performance Review
WELL Health Technologies announced robust third-quarter results, with revenue increasing 12% year-over-year and Adjusted EBITDA surpassing analyst expectations. This strong perform…
Nov 11, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Adjusts Welltower Price Target to $289 From $269, Maintains Buy Rating
UBS, a major financial institution, has adjusted its price target for Welltower Inc. upwards from $269 to $289, while reiterating a 'Buy' rating. This action signals a more optimis…
Nov 10, 2026
Corporate Catalyst
Bullish
Impact 55
JPMorgan Adjusts Price Target on Welltower to $273 From $260
JPMorgan has revised its price target for Welltower Inc. upwards from $260 to $273. This change reflects an updated, more favorable valuation outlook by the investment bank for the…
Nov 9, 2026
Corporate Catalyst
Bullish
Impact 55
BMO Capital Markets Adjusts Welltower Price Target to $275 from $270
BMO Capital Markets has updated its valuation for Welltower Inc., raising its price target by $5 to $275. This change reflects BMO's revised outlook on the healthcare real estate i…
Nov 2, 2026
Corporate Catalyst
Bullish
Impact 55
Evercore ISI Group Maintains Welltower at Outperform, Raises Price Target to $265
Evercore ISI Group's decision to maintain an 'Outperform' rating and raise the price target for Welltower Inc. to $265 from $256 signals continued analyst confidence in the company…
Oct 29, 2026
Corporate Catalyst
Neutral
Impact 65
Welltower Receives Analyst Rating Updates
Welltower Inc. (WELL) was the subject of multiple analyst actions, with Freedom Capital Markets initiating coverage with a 'Buy' rating and a $255 price target, and Cantor Fitzgera…
Oct 28, 2026
Corporate Catalyst
Neutral
Impact 55
WELL Health and HEALWELL AI Announce Competition Bureau No Action Letter
The Competition Bureau has issued a No Action Letter regarding WELL Health's acquisition of a controlling interest in HEALWELL AI, and HEALWELL's subsequent acquisition of Orion He…
Oct 27, 2026
Market Technicals
Bearish
Impact 55
BNP Paribas Adjusts Price Target on Welltower to $265 From $272
BNP Paribas, a significant financial institution, has lowered its price target for Welltower Inc. (WELL) from $272 to $265. This adjustment, while not a drastic change, signals a s…
Oct 26, 2026
Corporate Catalyst
Bullish
Impact 92
Welltower Inc. Reports Q3 2026 Financial Results
Welltower Inc. announced Q3 2026 results that surpassed analyst estimates for both revenue and normalized FFO, demonstrating robust operational performance. This positive surprise …
Sep 25, 2026
Corporate Catalyst
Neutral
Impact 65
JPMorgan Turns Contrarian on Interest Rates, Upgrades 3 REITs
JPMorgan Chase has made a significant contrarian call by upgrading three REITs (Welltower, Macerich, EastGroup Properties) to Overweight, despite the current high 10-year Treasury …
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 75
Welltower shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight rating and announced a $260 price target.
This headline represents a significant corporate catalyst for Welltower (WELL). An upgrade from Neutral to Overweight by a major investment bank like JP Morgan, coupled with a subs…
Sep 24, 2026
Corporate Catalyst
Bullish
Impact 65
JP Morgan Upgrades Welltower to Overweight, Announces $260 Price Target
JP Morgan's upgrade of Welltower (WELL) from Neutral to Overweight, coupled with a $260 price target, indicates a more bullish outlook from a prominent financial institution. This …
Sep 21, 2026
Corporate Catalyst
Bearish
Impact 55
Evercore ISI Group Maintains Outperform on Welltower, Lowers Price Target to $256
Evercore ISI Group's analyst Steve Sakwa has adjusted Welltower's price target from $260 to $256, while keeping an 'Outperform' rating. This minor downward revision of the price ta…
Sep 14, 2026
Corporate Catalyst
Neutral
Impact 55
TD Cowen Reiterates Buy on WELL Health Technologies, Maintains C$7 Price Target
TD Cowen analyst David Kwan has reaffirmed a 'Buy' rating and a C$7 price target for WELL Health Technologies. This action signals that the analyst's outlook on the company's funda…
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
Scotiabank Maintains Sector Outperform on Welltower, Raises Price Target to $251
Scotiabank analyst Nicholas Yulico maintained a 'Sector Outperform' rating on Welltower and raised the price target from $244 to $251. This action signals continued analyst confide…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 75
Welltower shares are trading higher after Wells Fargo and Morgan Stanley raised their respective price targets on the stock.
This news is a significant positive catalyst for Welltower (WELL). Upgraded price targets from prominent institutions like Wells Fargo and Morgan Stanley signal strong analyst conv…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 65
Morgan Stanley Maintains Overweight on Welltower, Raises Price Target to $251
Morgan Stanley's analyst Ronald Kamdem has raised the price target for Welltower (WELL) from $215 to $251 while maintaining an 'Overweight' rating. This upgrade signals increased c…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 55
Wells Fargo Maintains Overweight on Welltower, Raises Price Target to $266
Wells Fargo analyst John Kilichowski has maintained an 'Overweight' rating on Welltower (WELL) and raised the price target from $237 to $266. This action signals a strong vote of c…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 65
Keybanc Maintains Overweight on Welltower, Raises Price Target to $275
Keybanc analyst Austin Wurschmidt maintained an 'Overweight' rating on Welltower and raised the price target from $240 to $275. This action signals increased confidence from a prom…
Aug 3, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Welltower, Raises Price Target to $260
RBC Capital, through analyst Michael Carroll, reiterated its 'Outperform' rating on Welltower and raised the price target from $238 to $260. This action signals increased confidenc…
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Citigroup Maintains Buy on Welltower, Raises Price Target to $275
Citigroup analyst Nick Joseph maintained a 'Buy' rating on Welltower and raised the price target from $255 to $275. This analyst action signals continued confidence in Welltower's …
Jul 31, 2026
Corporate Catalyst
Bullish
Impact 55
Cantor Fitzgerald Maintains Overweight on Welltower, Raises Price Target to $260
Cantor Fitzgerald analyst Richard Anderson has maintained an 'Overweight' rating on Welltower (WELL) and raised the price target from $235 to $260. This action signals a strengthen…
Jul 30, 2026
Corporate Catalyst
Bullish
Impact 55
Evercore ISI Group Maintains Outperform on Welltower, Raises Price Target to $260
Evercore ISI Group analyst Steve Sakwa has maintained an 'Outperform' rating on Welltower (WELL) and raised the price target from $236 to $260. This analyst action is a positive si…
Jul 28, 2026
Corporate Catalyst
Bullish
Impact 92
Welltower shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 FFO guidance above estimates. Also, the company raised its quarterly dividend.
This headline represents a major positive corporate catalyst for Welltower. The combination of beating earnings expectations, raising future guidance, and increasing the dividend d…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 92
Welltower shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 FFO guidance above estimates. Also, the company raised its quarterly dividend.
This headline represents a major positive corporate catalyst for Welltower. The combination of exceeding earnings expectations, raising future guidance, and increasing the dividend…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 75
Welltower Raises FY2026 FFO Guidance from $6.21-$6.35 to $6.36-$6.44 vs $6.17 Est
Welltower, a healthcare real estate investment trust (REIT), has raised its FFO (Funds From Operations) guidance for FY2026. This is a significant positive development as FFO is a …
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 92
Welltower Q2 FFO $1.60 Beats $1.52 Estimate, Sales $3.545B Beat $3.277B Estimate
Welltower announced its Q2 earnings, reporting FFO of $1.60 per share, beating the $1.52 estimate by 4.58%, and sales of $3.545 billion, exceeding the $3.277 billion estimate by 8.…
Jul 22, 2026
Corporate Catalyst
Bullish
Impact 55
Mizuho Maintains Outperform on Welltower, Raises Price Target to $260
Mizuho analyst Omotayo Okusanya maintained an 'Outperform' rating on Welltower (WELL) and raised the price target from $239 to $260. This action signals a positive outlook from a p…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.